Multi-level considerations for optimal implementation of long-acting injectable antiretroviral therapy to treat people living with HIV: perspectives of health care providers participating in phase 3 trials

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1472-6963

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Multi-level considerations for optimal implementation of long-acting injectable antiretroviral therapy to treat people living with HIV: perspectives of health care providers participating in phase 3 trials ; volume:21 ; number:1 ; day:20 ; month:3 ; year:2021 ; pages:1-14 ; date:12.2021
BMC health services research ; 21, Heft 1 (20.3.2021), 1-14, 12.2021

Creator: Mantsios, Andrea
Murray, Miranda
Karver, Tahilin S.
Davis, Wendy
Galai, Noya
Kumar, Princy
Swindells, Susan
Bredeek, U. Fritz
García, Rafael Rubio
Antela, Antonio
Gomis, Santiago Cenoz
Bernáldez, Miguel Pascual
Czarnogorski, Maggie
Hudson, Krischan
Walters, Nicki
Kerrigan, Deanna

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12913-021-06214-9

URN: urn:nbn:de:101:1-2021050616015114583548

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:49 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Mantsios, Andrea
Murray, Miranda
Karver, Tahilin S.
Davis, Wendy
Galai, Noya
Kumar, Princy
Swindells, Susan
Bredeek, U. Fritz
García, Rafael Rubio
Antela, Antonio
Gomis, Santiago Cenoz
Bernáldez, Miguel Pascual
Czarnogorski, Maggie
Hudson, Krischan
Walters, Nicki
Kerrigan, Deanna
SpringerLink (Online service)

Other Objects (12)

Long-acting injectable atovaquone nanomedicines for malaria prophylaxis

The Use of Long-Acting Injectable Antipsychotics in Schizophrenia

Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview

Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs

Attitudes of European physicians towards the use of long-acting injectable antipsychotics

Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors

Improvement of long-term outcome in schizophrenia: switching to risperidone long-acting injectable

Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study

Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy

Long-Acting Reversible Contraception

Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077

Assessing readiness to implement long-acting injectable HIV antiretroviral therapy: provider and staff perspectives

Long-acting injectable atovaquone nanomedicines for malaria prophylaxis

The Use of Long-Acting Injectable Antipsychotics in Schizophrenia

Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview

Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs

Attitudes of European physicians towards the use of long-acting injectable antipsychotics

Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors

Improvement of long-term outcome in schizophrenia: switching to risperidone long-acting injectable

Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study

Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy

Long-Acting Reversible Contraception

Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077

Assessing readiness to implement long-acting injectable HIV antiretroviral therapy: provider and staff perspectives

Long-acting injectable atovaquone nanomedicines for malaria prophylaxis

The Use of Long-Acting Injectable Antipsychotics in Schizophrenia

Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview

Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs

Attitudes of European physicians towards the use of long-acting injectable antipsychotics

Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors

Improvement of long-term outcome in schizophrenia: switching to risperidone long-acting injectable

Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study

Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy

Long-Acting Reversible Contraception

Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077

Assessing readiness to implement long-acting injectable HIV antiretroviral therapy: provider and staff perspectives

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Multi-level considerations for optimal implementation of long-acting injectable antiretroviral therapy to treat people living with HIV: perspectives of health care providers participating in phase 3 trials

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Long-acting injectable atovaquone nanomedicines for malaria prophylaxis

The Use of Long-Acting Injectable Antipsychotics in Schizophrenia

Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview

Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs

Attitudes of European physicians towards the use of long-acting injectable antipsychotics

Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors

Improvement of long-term outcome in schizophrenia: switching to risperidone long-acting injectable

Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study

Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy

Long-Acting Reversible Contraception

Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077

Assessing readiness to implement long-acting injectable HIV antiretroviral therapy: provider and staff perspectives

Long-acting injectable atovaquone nanomedicines for malaria prophylaxis

The Use of Long-Acting Injectable Antipsychotics in Schizophrenia

Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview

Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs

Attitudes of European physicians towards the use of long-acting injectable antipsychotics

Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors

Improvement of long-term outcome in schizophrenia: switching to risperidone long-acting injectable

Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study

Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy

Long-Acting Reversible Contraception

Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077

Assessing readiness to implement long-acting injectable HIV antiretroviral therapy: provider and staff perspectives

Long-acting injectable atovaquone nanomedicines for malaria prophylaxis

The Use of Long-Acting Injectable Antipsychotics in Schizophrenia

Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview

Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs

Attitudes of European physicians towards the use of long-acting injectable antipsychotics

Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors

Improvement of long-term outcome in schizophrenia: switching to risperidone long-acting injectable

Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study

Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy

Long-Acting Reversible Contraception

Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077

Assessing readiness to implement long-acting injectable HIV antiretroviral therapy: provider and staff perspectives

Related objects

Reset password